These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24615197)

  • 1. [The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].
    Jassem J; Biernat W; Bryl M; Chorostowska-Wynimko J; Dziadziuszko R; Krawczyk P; Kordek R; Kowalski DM; Krzakowski M; Olszewski W; Orłowski T; Ramlau R; Rzyman W
    Pneumonol Alergol Pol; 2014; 82(2):133-49. PubMed ID: 24615197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural mesothelioma: an update on diagnosis and treatment options.
    Kondola S; Manners D; Nowak AK
    Ther Adv Respir Dis; 2016 Jun; 10(3):275-88. PubMed ID: 26873306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
    Signorelli D; Macerelli M; Proto C; Vitali M; Cona MS; Agustoni F; Zilembo N; Platania M; Trama A; Gallucci R; Ganzinelli M; Pelosi G; Pastorino U; de Braud F; Garassino MC; Lo Russo G
    Tumori; 2016; 102(1):18-30. PubMed ID: 26481865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies for malignant pleural mesothelioma.
    Scherpereel A; Wallyn F; Albelda SM; Munck C
    Lancet Oncol; 2018 Mar; 19(3):e161-e172. PubMed ID: 29508763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of bevacizumab in the treatment of malignant pleural mesothelioma.
    Brosseau S; Assoun S; Naltet C; Steinmetz C; Gounant V; Zalcman G
    Future Oncol; 2017 Dec; 13(28):2537-2546. PubMed ID: 29086616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?
    Addeo A; Buffoni L; Di Maio M
    JAMA Oncol; 2017 Sep; 3(9):1170-1171. PubMed ID: 28114625
    [No Abstract]   [Full Text] [Related]  

  • 7. Searching for targets for the systemic therapy of mesothelioma.
    Stahel RA; Weder W; Felley-Bosco E; Petrausch U; Curioni-Fontecedro A; Schmitt-Opitz I; Peters S
    Ann Oncol; 2015 Aug; 26(8):1649-60. PubMed ID: 25722383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody drug conjugates in thoracic malignancies.
    Pacheco JM; Camidge DR
    Lung Cancer; 2018 Oct; 124():260-269. PubMed ID: 30268471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases.
    Metaxas Y; Cathomas R; Mark M; von Moos R
    Lung Cancer; 2016 Dec; 102():136-138. PubMed ID: 27440191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-tumor immunotherapy in malignant pleural mesothelioma].
    Scherpereel A; Willemin MC; Wasielewski E; Dhalluin X
    Rev Mal Respir; 2018 Apr; 35(4):465-476. PubMed ID: 29415822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperthermic chemoperfusion of the pleural cavity in the combined treatment for malignant pleural mesothelioma].
    Levchenko EV; Mamontov OIu; Senchik KIu; Barchuk AS; Gel'fond ML
    Vopr Onkol; 2014; 60(4):482-5. PubMed ID: 25552068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesothelioma: closer to the target?
    Pass HI
    Lancet Oncol; 2013 May; 14(6):448-9. PubMed ID: 23583605
    [No Abstract]   [Full Text] [Related]  

  • 13. IASLC 2020 World Conference on Lung Cancer.
    Venkatesan P
    Lancet Respir Med; 2020 Oct; 8(10):e76. PubMed ID: 32866439
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].
    Marco S; Tomasini P; Greillier L; Barlesi F
    Rev Mal Respir; 2011 Dec; 28(10):1216-29. PubMed ID: 22152931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma.
    Manegold C; Stahel RA;
    Ann Oncol; 2005; 16 Suppl 1():i32-3. PubMed ID: 15888745
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant pleural mesothelioma in a young adult with no known exposure to asbestos.
    Espinosa Muñoz E; Ramírez Ocaña D; Gutiérrez Cardo AL
    Arch Bronconeumol; 2016 Dec; 52(12):615-616. PubMed ID: 27156205
    [No Abstract]   [Full Text] [Related]  

  • 17. Deciduoid pleural mesothelioma in an adolescent.
    Arango-Tomás E; Algar-Algar FJ; Salvatierra Velázquez A
    Arch Bronconeumol; 2013 May; 49(5):218-9. PubMed ID: 23265622
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical Management of Malignant Pleural Mesothelioma: An Update of Clinical Evidence.
    Cao C; Akhunji Z; Fu B; Wilcox C; Novis E; Tian DH; Yan TD
    Semin Thorac Cardiovasc Surg; 2015; 27(1):6-8. PubMed ID: 26074102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.
    Opitz I; Bueno R; Lim E; Pass H; Pastorino U; Boeri M; Rocco G;
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):602-6. PubMed ID: 24623168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iterative surgery for recurrent malignant pleural mesothelioma in long-term survivor.
    Leuzzi G; Melis E; Forcella D; Facciolo F
    ANZ J Surg; 2017 Nov; 87(11):946-947. PubMed ID: 25879924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.